BiotechTube
Home/Merlin Biotech/Randall N. Hyer, MD, PhD, MPH
RN

Randall N. Hyer, MD, PhD, MPH

Chief Executive Officer

Merlin Biotech

Therapeutic Areas

OncologyInfectious Disease

Merlin Biotech Pipeline

DrugIndicationPhase
MER-101Adult Solid Cancers; Pediatric Sarcomas (e.g., Ewing Sarcoma)Pre-clinical

Leadership Team at Merlin Biotech

IH
Ian Henrich, PhD
Vice President, Research and Development
NS
Nick Spring, DipM, MCIM
Business Strategy & Commercialization
YS
Yolanda Sanchez, PhD, MS
Clinical Study Design & Drug Development
View full Merlin Biotech profile